Original Literature | Model OverView |
---|---|
Publication
Title
Developmental plasticity of lymphocytes.
Affiliation
Universidad de Salamanca, Campus Miguel de Unamuno, 37007 Salamanca, Spain.
Abstract
Experimental perturbation of signaling or transcription factor networks has beenused to study the developmental potential of lymphoid progenitors,lineage-committed precursors and mature lymphocytes. Common lymphoid progenitorsand uncommitted pro-T cells can be efficiently diverted into myeloid orerythroid lineages by ectopic cytokine signaling or retroviral expression of themyeloid C/EBPalpha or erythroid GATA1 transcription factor. Forced C/EBPalphaexpression furthermore induces direct transdifferentiation of immaturethymocytes or B cells into macrophages. Notably, conditional inactivation of theB cell commitment factor Pax5 is sufficient to convert mature B cells intofunctional T cells via dedifferentiation to uncommitted progenitors. Togetherthese experiments have uncovered an unanticipated developmental plasticity oflymphocytes, which may account for lineage switches observed in humanmalignancies.
PMID
18472258
|
Entity
IL-7
--
MO000016830
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1767
10
infinite
0
InterPro | IPR001181 |
TRANSPATH | MO000016830 |
--
C/EBPalpha
--
MO000019417
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3982
10
infinite
0
InterPro | IPR000217 |
TRANSPATH | MO000019417 |
--
GATA-1
--
MO000032476
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m11427
10
infinite
0
InterPro | IPR000679 |
TRANSPATH | MO000032476 |
--
csml-variable:Double
m362249
10
infinite
0
Affymetrix | 115110_at |
Ensembl | ENSMUSG00000057098 |
InterPro | IPR001092 |
MGD | 9830166E18Rik |
Proteome | HumanPSD/Ebf1 |
RGD | Ebf1 |
RefSeq | NM_007897 |
TRANSFAC | T09926 |
TRANSPATH | MO000092644 |
Unigene | Mm.339905 |
UniProt | Q07802 |
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m10
0
infinite
0
--
--
e100
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m100
0
infinite
0
--
--
e101
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m101
0
infinite
0
--
IL-7:IL-7R
--
e102
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m102
0
infinite
0
--
Macrophage
--
e103
cso30:c:Cell
cso30:i:CC_Extracellular
--
csml-variable:Double
m103
0
infinite
0
--
erythropoietin
--
e104
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m104
0
infinite
0
--
SCF
--
e105
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m105
0
infinite
0
--
Erythroblast
--
e106
cso30:c:Cell
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m106
0
infinite
0
--
megakaryocytes
--
e109
cso30:c:Cell
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m109
0
infinite
0
--
--
e11
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m11
0
infinite
0
--
Erythrocytes
--
e110
cso30:c:Cell
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m110
0
infinite
0
--
--
e111
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m111
0
infinite
0
--
--
e112
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m112
0
infinite
0
--
--
e113
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m113
0
infinite
0
--
--
e114
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m114
0
infinite
0
--
--
e115
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m115
0
infinite
0
--
--
e116
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m116
0
infinite
0
--
--
e117
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m117
0
infinite
0
--
--
e118
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m118
0
infinite
0
--
--
e119
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m119
0
infinite
0
--
--
e12
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m12
0
infinite
0
--
--
e120
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m120
0
infinite
0
--
--
e121
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m121
0
infinite
0
--
--
e122
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m122
0
infinite
0
--
--
e123
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m123
0
infinite
0
--
--
e124
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m124
0
infinite
0
--
--
e125
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m125
0
infinite
0
--
--
e126
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m126
0
infinite
0
--
--
e127
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m127
0
infinite
0
--
--
e128
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m128
0
infinite
0
--
--
e129
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m129
0
infinite
0
--
--
e13
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m13
0
infinite
0
--
--
e130
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m130
0
infinite
0
--
--
e131
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m131
0
infinite
0
--
IL-2:IL-2R
--
e132
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m132
0
infinite
0
--
--
e133
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m133
0
infinite
0
--
--
e134
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m134
0
infinite
0
--
--
e135
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m135
0
infinite
0
--
--
e136
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m136
0
infinite
0
--
--
e137
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m137
0
infinite
0
--
--
e138
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m138
0
infinite
0
--
--
e139
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m139
0
infinite
0
--
--
e14
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m14
0
infinite
0
--
--
e140
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m140
0
infinite
0
--
--
e141
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m141
0
infinite
0
--
--
e142
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m142
0
infinite
0
--
--
e143
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m143
0
infinite
0
--
--
e144
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m144
0
infinite
0
--
--
e145
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m145
0
infinite
0
--
--
e146
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m146
0
infinite
0
--
--
e147
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m147
0
infinite
0
--
--
e148
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m148
0
infinite
0
--
IL-2:IL-2R
--
e149
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m149
0
infinite
0
--
--
e15
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m15
0
infinite
0
--
GM-CSF:GM-CSFR
--
e150
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m150
0
infinite
0
--
--
e156
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m156
0
infinite
0
--
--
e157
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m157
0
infinite
0
--
--
e158
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m158
0
infinite
0
--
--
e159
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m159
0
infinite
0
--
B-lymphoid genes
--
e16
cso30:c:mRNA
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m16
0
infinite
0
--
--
e160
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m160
0
infinite
0
--
--
e161
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m161
0
infinite
0
--
--
e162
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m162
0
infinite
0
--
--
e163
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m163
0
infinite
0
--
--
e164
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m164
0
infinite
0
--
--
e165
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m165
0
infinite
0
--
--
e166
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m166
0
infinite
0
--
--
e167
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m167
0
infinite
0
--
--
e168
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m168
0
infinite
0
--
B-lineage inappropriate genes
--
e17
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m17
0
infinite
0
--
csml-variable:Double
m170
0
infinite
0
--
csml-variable:Double
m175
0
infinite
0
--
--
e176
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m176
0
infinite
0
--
--
e177
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m177
0
infinite
0
--
--
e178
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m178
0
infinite
0
--
--
e179
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m179
0
infinite
0
--
IL-7:IL-7R
--
e18
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m18
0
infinite
0
--
--
e180
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m180
0
infinite
0
--
--
e181
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m181
0
infinite
0
--
--
e182
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m182
0
infinite
0
--
--
e183
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m183
0
infinite
0
--
--
e184
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m184
0
infinite
0
--
--
e185
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m185
0
infinite
0
--
--
e186
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m186
0
infinite
0
--
--
e187
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m187
0
infinite
0
--
--
e188
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m188
0
infinite
0
--
--
e189
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m189
0
infinite
0
--
B-cell specific genes
--
e19
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m19
0
infinite
0
--
--
e190
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m190
0
infinite
0
--
--
e191
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m191
0
infinite
0
--
--
e192
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m192
0
infinite
0
--
--
e193
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m193
0
infinite
0
--
--
e194
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m194
0
infinite
0
--
--
e196
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m196
0
infinite
0
--
Foreign antigens
--
e197
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m197
0
infinite
0
--
BCR{active}
--
e198
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m198
10
infinite
0
TRANSPATH | MO000017690 |
--
Plasma cells
--
e199
cso30:c:Cell
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m199
0
infinite
0
--
LLMPs
--
e2
cso30:c:Cell
cso30:i:CC_CellComponent
--
csml-variable:Double
m2
0
infinite
0
--
Blimp1
--
e20
cso30:c:mRNA
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m20
0
infinite
0
--
HSCs
--
e21
cso30:c:Cell
cso30:i:CC_Extracellular
--
csml-variable:Double
m21
0
infinite
0
--
--
e22
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m22
0
infinite
0
--
--
e23
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m23
0
infinite
0
--
--
e24
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m24
0
infinite
0
--
--
e25
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m25
0
infinite
0
--
--
e26
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m26
0
infinite
0
--
--
e27
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m27
0
infinite
0
--
--
e28
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m28
0
infinite
0
--
--
e29
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m29
0
infinite
0
--
Erythroid cells
--
e3
cso30:c:Cell
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m3
0
infinite
0
--
--
e30
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m30
0
infinite
0
--
--
e31
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m31
0
infinite
0
--
--
e32
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m32
0
infinite
0
--
--
e33
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m33
0
infinite
0
--
--
e34
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m34
0
infinite
0
--
--
e35
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m35
0
infinite
0
--
--
e36
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m36
0
infinite
0
--
--
e37
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m37
0
infinite
0
--
--
e38
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m38
0
infinite
0
--
--
e39
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m39
0
infinite
0
--
Megakaryocytes
--
e4
cso30:c:Cell
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m4
0
infinite
0
--
--
e40
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m40
0
infinite
0
--
--
e41
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m41
0
infinite
0
--
--
e42
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m42
0
infinite
0
--
--
e43
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m43
0
infinite
0
--
--
e44
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m44
0
infinite
0
--
--
e45
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m45
0
infinite
0
--
--
e46
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m46
0
infinite
0
--
--
e47
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m47
0
infinite
0
--
--
e48
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m48
0
infinite
0
--
--
e49
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m49
0
infinite
0
--
Multipotent progenitors
--
e5
cso30:c:Cell
cso30:i:CC_Extracellular
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
Myeloid cells
--
e6
cso30:c:Cell
cso30:i:CC_CellComponent
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
--
e63
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m63
0
infinite
0
--
--
e64
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m64
0
infinite
0
--
Delta-like 4
--
e65
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m65
0
infinite
0
--
Delta-like 4:Notch1
--
e66
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m66
0
infinite
0
--
Granulocyte
--
e67
cso30:c:Cell
cso30:i:CC_Extracellular
--
csml-variable:Double
m67
0
infinite
0
--
Monocyte
--
e68
cso30:c:Cell
cso30:i:CC_Extracellular
--
csml-variable:Double
m68
0
infinite
0
--
IL-2:IL-2R
--
e69
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m69
0
infinite
0
--
ELPs
--
e7
cso30:c:Cell
cso30:i:CC_CellComponent
--
csml-variable:Double
m7
0
infinite
0
--
--
e71
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m71
0
infinite
0
--
GM-CSF:GM-CSFR
--
e72
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m72
0
infinite
0
--
DC
--
e73
cso30:c:Cell
cso30:i:CC_Extracellular
--
csml-variable:Double
m73
0
infinite
0
--
Pam3CSK4
--
e74
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m74
0
infinite
0
--
TLR2:Pam3CSK4
--
e75
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m75
0
infinite
0
--
LPS:TLR4
--
e76
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m76
0
infinite
0
--
--
e77
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m77
0
infinite
0
--
--
e78
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m78
0
infinite
0
--
--
e79
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m79
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e80
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m80
0
infinite
0
--
--
e81
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m81
0
infinite
0
--
--
e82
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m82
0
infinite
0
--
--
e83
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m83
0
infinite
0
--
--
e84
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m84
0
infinite
0
--
--
e85
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m85
0
infinite
0
--
--
e86
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m86
0
infinite
0
--
--
e87
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m87
0
infinite
0
--
--
e88
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m88
0
infinite
0
--
--
e89
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m89
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
e90
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m90
0
infinite
0
--
--
e91
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m91
0
infinite
0
--
--
e92
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m92
0
infinite
0
--
--
e93
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m93
0
infinite
0
--
--
e94
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m94
0
infinite
0
--
--
e95
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m95
0
infinite
0
--
--
e96
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m96
0
infinite
0
--
--
e97
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m97
0
infinite
0
--
--
e98
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m98
0
infinite
0
--
--
e99
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m99
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m5*0.1
nodelay
--
0
PMID: 18472258 Hematopoietic stem cells (HSCs) in the bone marrow give rise to all blood cell types by differentiating via multipotent progenitors into common myeloid progenitors (CMPs) or lymphoid-primed multipotent progenitors (LMPPs).
--
and
mass
coefficient1:0.1
coefficient2:1.0
1.0*0.1
nodelay
--
0
--
p11
p11
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c21 : 1
stoichiometry:c22 : 1
stoichiometry:c23 : 1
m1767*m1776*0.1
nodelay
--
0
PMID: 18472258,12208884,17440452,17582344 Entry of CLPs into the B cell lineage critically depends on signaling of the IL-7 receptor and expression of the three transcription factors E2A, EBF1, and Pax5
PMID: 18472258,12208884,17440452,17582344 Entry of CLPs into the B cell lineage critically depends on signaling of the IL-7 receptor and expression of the three transcription factors E2A, EBF1, and Pax5
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c26 : 1
stoichiometry:c27 : 1
m21*0.1
nodelay
--
0
PMID: 18472258 Hematopoietic stem cells (HSCs) in the bone marrow give rise to all blood cell types by differentiating via multipotent progenitors into common myeloid progenitors (CMPs) or lymphoid-primed multipotent progenitors (LMPPs). ) PMID: 18472258, 17582341 T cells are also derived from HSCs in the bone marrow and yet develop in the thymus. Several hematopoietic progenitors (MPPs, LMPPs, ELPs, CLPs, and pre?pro-B cells) in the bone marrow have the potential to migrate to the thymus, where they promote T cell development
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c29 : 1
stoichiometry:c33 : 1
m65*m10514*0.1
nodelay
--
0
PMID: 18472258,17440450 Upon entry into the thymus, the TSPs experience a high density of the Notch ligand Delta-like 4, which is expressed on cortical epithelial cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c30 : 1
stoichiometry:c31 : 1
m21*0.1
nodelay
--
0
PMID: 18472258,17582341 T cells are also derived from HSCs in the bone marrow and yet develop in the thymus. Several hematopoietic progenitors (MPPs, LMPPs, ELPs, CLPs, and pre?pro-B cells) in the bone marrow have the potential to migrate to the thymus, where they promote T cell development
PMID: 18472258,17582341 Currently, the LMPPs and ELPs are considered to be the most probable candidates for the thymus-settling progenitor (TSP) that initiates T lymphopoiesis
PMID: 18472258,17582341 Currently, the LMPPs and ELPs are considered to be the most probable candidates for the thymus-settling progenitor (TSP) that initiates T lymphopoiesis
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c35 : 1
stoichiometry:c36 : 1
m66*0.1
nodelay
--
0
PMID: 18472258,17440450,15356142 Signaling through the Notch1 receptor induces pro-T cell development by activating Gata3, Tcf7 (Tcf1) and the T cell gene expression program
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c38 : 1
m66*0.1
nodelay
--
0
PMID: 18472258,17440450,15356142 Signaling through the Notch1 receptor induces pro-T cell development by activating Gata3, Tcf7 (Tcf1) and the T cell gene expression program
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m1*0.1
nodelay
--
0
PMID: 18472258,15851035 Erythroid cells and megakaryocytes largely arise from CMPs, while myeloid cells can develop from either CMPs or LMPPs
p20
p20
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c39 : 1
stoichiometry:c40 : 1
stoichiometry:c41 : 1
m69*0.1
nodelay
--
0
PMID: 18472258,11014194 Stimulation with human IL-2 efficiently redirects these transgenic CLPs to the granulocyte and monocyte (GM) lineages even under lymphoid differentiation conditions (IL-7 plus stromal OP9 cells), which normally allow wild-type CLPs to develop only into B lymphocytes
p21
p21
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c42 : 1
stoichiometry:c43 : 1
stoichiometry:c44 : 1
m132*0.1
nodelay
--
0
PMID: 18472258,11014194,11917122 Ectopic hIL-2R signaling also induces uncommitted DN1 and DN2 pro-T cells to differentiate into granulocytes and macrophages, which carry Dbeta1-Jbeta1 rearrangements at the TCRbeta locus as genetic evidence of their lineage conversion
p21
p22
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c46 : 1
stoichiometry:c47 : 1
m149*0.1
nodelay
--
0
PMID: 18472258,11014194,11917122 Ectopic hIL-2R signaling also induces uncommitted DN1 and DN2 pro-T cells to differentiate into granulocytes and macrophages, which carry Dbeta1-Jbeta1 rearrangements at the TCRbeta locus as genetic evidence of their lineage conversion
p23
p23
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c51 : 1
stoichiometry:c52 : 1
stoichiometry:c54 : 1
m72*0.1
nodelay
--
0
PMID: 18472258,11014194 Indeed, transgenic expression of a human GM-CSF receptor instructs CLPs and DN2 thymocytes to differentiate along the GM and DC lineages in response to hGM-CSF addition
p23
p24
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c49 : 1
stoichiometry:c53 : 1
stoichiometry:c55 : 1
m150*0.1
nodelay
--
0
PMID: 18472258,11014194 Indeed, transgenic expression of a human GM-CSF receptor instructs CLPs and DN2 thymocytes to differentiate along the GM and DC lineages in response to hGM-CSF addition
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c59 : 1
m93848*0.1
nodelay
--
0
PMID: 18472258,16782035 CLPs express high levels of the Toll-like receptor 2 (TLR2) and lower levels of TLR4.Indeed, the TLR2 ligand Pam3CSK4 or TLR4 ligand LPS efficiently redirects the developmental fate of wild-type CLPs toward DC differentiation under lymphoid culture conditions (SCF, Flt3L, and IL-7; Figure 2A), which normally promote B cell development
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c61 : 1
m93614*0.1
nodelay
--
0
PMID: 18472258,16782035 CLPs express high levels of the Toll-like receptor 2 (TLR2) and lower levels of TLR4.Indeed, the TLR2 ligand Pam3CSK4 or TLR4 ligand LPS efficiently redirects the developmental fate of wild-type CLPs toward DC differentiation under lymphoid culture conditions (SCF, Flt3L, and IL-7; Figure 2A), which normally promote B cell development
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c62 : 1
stoichiometry:c63 : 1
stoichiometry:c64 : 1
m3964*m74*0.1
nodelay
--
0
PMID: 18472258,16782035 Indeed, the TLR2 ligand Pam3CSK4 or TLR4 ligand LPS efficiently redirects the developmental fate of wild-type CLPs toward DC differentiation under lymphoid culture conditions (SCF, Flt3L, and IL-7; Figure 2A), which normally promote B cell development
p27
p28
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c65 : 1
stoichiometry:c66 : 1
stoichiometry:c67 : 1
m155666*m3961*0.1
nodelay
--
0
PMID: 18472258,16782035 Indeed, the TLR2 ligand Pam3CSK4 or TLR4 ligand LPS efficiently redirects the developmental fate of wild-type CLPs toward DC differentiation under lymphoid culture conditions (SCF, Flt3L, and IL-7; Figure 2A), which normally promote B cell development
p29
p29
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c68 : 1
stoichiometry:c73 : 1
stoichiometry:c75 : 1
stoichiometry:c77 : 1
stoichiometry:c69 : 1
m76*m1943*m1767*m63933*0.1
nodelay
--
0
PMID: 18472258, 16782035 Indeed, the TLR2 ligand Pam3CSK4 or TLR4 ligand LPS efficiently redirects the developmental fate of wild-type CLPs toward DC differentiation under lymphoid culture conditions (SCF, Flt3L, and IL-7; Figure 2A), which normally promote B cell development
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
m1*0.1
nodelay
--
0
PMID: 18472258,15851035 Erythroid cells and megakaryocytes largely arise from CMPs, while myeloid cells can develop from either CMPs or LMPPs
p29
p30
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c70 : 1
stoichiometry:c72 : 1
stoichiometry:c74 : 1
stoichiometry:c76 : 1
stoichiometry:c71 : 1
m75*m1943*m1767*m63933*0.1
nodelay
--
0
PMID: 18472258, 16782035 Indeed, the TLR2 ligand Pam3CSK4 or TLR4 ligand LPS efficiently redirects the developmental fate of wild-type CLPs toward DC differentiation under lymphoid culture conditions (SCF, Flt3L, and IL-7; Figure 2A), which normally promote B cell development
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c78 : 1
stoichiometry:c79 : 1
m93306*0.1
nodelay
--
0
PMID: 18472258,12881423 Retroviral expression of C/EBPalpha, GATA1, or GATA2 strongly enhances the macrophage differentiation potential of Pax5 knockout pro-B cells under lymphoid culture conditions (IL-7 plus stromal ST2 cells), whereas GATA1 expression induces erythroblast development in the presence of erythropoietin and stem cell factor (SCF)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c80 : 1
stoichiometry:c81 : 1
m94377*0.1
nodelay
--
0
PMID: 18472258,12881423 Retroviral expression of C/EBPalpha, GATA1, or GATA2 strongly enhances the macrophage differentiation potential of Pax5 knockout pro-B cells under lymphoid culture conditions (IL-7 plus stromal ST2 cells), whereas GATA1 expression induces erythroblast development in the presence of erythropoietin and stem cell factor (SCF)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c82 : 1
stoichiometry:c83 : 1
m94470*0.1
nodelay
--
0
PMID: 18472258,12881423 Retroviral expression of C/EBPalpha, GATA1, or GATA2 strongly enhances the macrophage differentiation potential of Pax5 knockout pro-B cells under lymphoid culture conditions (IL-7 plus stromal ST2 cells), whereas GATA1 expression induces erythroblast development in the presence of erythropoietin and stem cell factor (SCF)
p34
p34
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c84 : 1
stoichiometry:c86 : 1
stoichiometry:c85 : 1
m3982*m102*0.1
nodelay
--
0
PMID: 18472258,12881423 Retroviral expression of C/EBPalpha, GATA1, or GATA2 strongly enhances the macrophage differentiation potential of Pax5 knockout pro-B cells under lymphoid culture conditions (IL-7 plus stromal ST2 cells), whereas GATA1 expression induces erythroblast development in the presence of erythropoietin and stem cell factor (SCF)
p34
p35
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c88 : 1
stoichiometry:c89 : 1
m11427*m102*0.1
nodelay
--
0
PMID: 18472258,12881423 Retroviral expression of C/EBPalpha, GATA1, or GATA2 strongly enhances the macrophage differentiation potential of Pax5 knockout pro-B cells under lymphoid culture conditions (IL-7 plus stromal ST2 cells), whereas GATA1 expression induces erythroblast development in the presence of erythropoietin and stem cell factor (SCF)
p34
p36
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c90 : 1
stoichiometry:c91 : 1
stoichiometry:c92 : 1
m11425*m102*0.1
nodelay
--
0
PMID: 18472258,12881423 Retroviral expression of C/EBPalpha, GATA1, or GATA2 strongly enhances the macrophage differentiation potential of Pax5 knockout pro-B cells under lymphoid culture conditions (IL-7 plus stromal ST2 cells), whereas GATA1 expression induces erythroblast development in the presence of erythropoietin and stem cell factor (SCF)
p34
p37
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c94 : 1
stoichiometry:c95 : 1
stoichiometry:c96 : 1
m11427*m105*m104*0.1
nodelay
--
0
PMID: 18472258,12881423 Retroviral expression of C/EBPalpha, GATA1, or GATA2 strongly enhances the macrophage differentiation potential of Pax5 knockout pro-B cells under lymphoid culture conditions (IL-7 plus stromal ST2 cells), whereas GATA1 expression induces erythroblast development in the presence of erythropoietin and stem cell factor (SCF)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c97 : 1
stoichiometry:c98 : 1
m107*0.1
nodelay
--
0
PMID: 18472258,14499119 Moreover, CLPs fail to realize their B cell potential upon forced expression of GATA1, but instead develop into megakaryocytes and erythrocytes (MegE) even under lymphoid cytokine conditions (SCF and IL-7)
p39
p39
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c99 : 1
stoichiometry:c100 : 1
stoichiometry:c101 : 1
stoichiometry:c102 : 1
stoichiometry:c103 : 1
m108*m1767*m105*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c9 : 1
stoichiometry:c10 : 1
m2*0.1
nodelay
--
0
PMID: 18472258,15851035 Erythroid cells and megakaryocytes largely arise from CMPs, while myeloid cells can develop from either CMPs or LMPPs
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c57 : 1
m70*0.1
nodelay
--
0
PMID: 18472258,16407117 Likewise, retroviral C/EBPalpha expression efficiently diverts CLPs as well as DN1 and DN2 pro-T cells into the GM lineages
p41
p41
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c104 : 1
stoichiometry:c105 : 1
stoichiometry:c106 : 1
m151*0.1
nodelay
--
0
PMID: 18472258,16407117 Likewise, retroviral C/EBPalpha expression efficiently diverts CLPs as well as DN1 and DN2 pro-T cells into the GM lineages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c107 : 1
stoichiometry:c108 : 1
m152*0.1
nodelay
--
0
PMID: 18472258,16407117 Likewise, retroviral C/EBPalpha expression efficiently diverts CLPs as well as DN1 and DN2 pro-T cells into the GM lineages
p41
p43
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c109 : 1
stoichiometry:c110 : 1
stoichiometry:c111 : 1
m154*0.1
nodelay
--
0
PMID: 18472258,16407117 Likewise, retroviral C/EBPalpha expression efficiently diverts CLPs as well as DN1 and DN2 pro-T cells into the GM lineages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c112 : 1
stoichiometry:c113 : 1
m153*0.1
nodelay
--
0
PMID: 18472258,16407117 Likewise, retroviral C/EBPalpha expression efficiently diverts CLPs as well as DN1 and DN2 pro-T cells into the GM lineages
p41
p45
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c114 : 1
stoichiometry:c115 : 1
stoichiometry:c116 : 1
m155*0.1
nodelay
--
0
PMID: 18472258,16407117 Likewise, retroviral C/EBPalpha expression efficiently diverts CLPs as well as DN1 and DN2 pro-T cells into the GM lineages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c117 : 1
stoichiometry:c118 : 1
m169*0.1
nodelay
--
0
PMID: 18472258,17603486,12881423 However in the absence of Notch ligands, ectopic GATA3 expression induces myeloid differentiation of Pax5 knockout pro-B cells or mast cell development of DN1 and DN2 pro-T cells
p47
p47
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c119 : 1
stoichiometry:c120 : 1
m13174*0.1
nodelay
--
0
PMID: 18472258,17603486,12881423 However in the absence of Notch ligands, ectopic GATA3 expression induces myeloid differentiation of Pax5 knockout pro-B cells or mast cell development of DN1 and DN2 pro-T cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c121 : 1
stoichiometry:c123 : 1
m171*0.1
nodelay
--
0
PMID: 18472258,17603486,12881423 However in the absence of Notch ligands, ectopic GATA3 expression induces myeloid differentiation of Pax5 knockout pro-B cells or mast cell development of DN1 and DN2 pro-T cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c122 : 1
stoichiometry:c124 : 1
m172*0.1
nodelay
--
0
PMID: 18472258,17603486,12881423 However in the absence of Notch ligands, ectopic GATA3 expression induces myeloid differentiation of Pax5 knockout pro-B cells or mast cell development of DN1 and DN2 pro-T cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m2*0.1
nodelay
--
0
PMID: 18472258,9393859,17582343 Activation of the lymphoid Rag1 and Rag2 genes in LMPP cells characterizes the emergence of the earliest lymphocyte progenitors (ELPs), which subsequently differentiate into common lymphoid progenitors (CLPs) with their characteristic B, T, and NK cell potential PMID: 18472258,17582341 T cells are also derived from HSCs in the bone marrow and yet develop in the thymus. Several hematopoietic progenitors (MPPs, LMPPs, ELPs, CLPs, and pre?pro-B cells) in the bone marrow have the potential to migrate to the thymus, where they promote T cell development
p47
p50
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c125 : 1
stoichiometry:c126 : 1
m173*0.1
nodelay
--
0
PMID: 18472258,17603486,12881423 However in the absence of Notch ligands, ectopic GATA3 expression induces myeloid differentiation of Pax5 knockout pro-B cells or mast cell development of DN1 and DN2 pro-T cells
p47
p51
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c127 : 1
stoichiometry:c128 : 1
m174*0.1
nodelay
--
0
PMID: 18472258,17603486,12881423 However in the absence of Notch ligands, ectopic GATA3 expression induces myeloid differentiation of Pax5 knockout pro-B cells or mast cell development of DN1 and DN2 pro-T cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c129 : 1
stoichiometry:c130 : 1
m195*0.1
nodelay
--
0
PMID: 18472258,17440452 Pax5 directly activates target genes coding for essential components of BCR signaling such as the signal-transducing chain Ig¦Á (CD79a), the costimulatory receptor CD19 and the central adaptor protein BLNK (SLP65)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c131 : 1
stoichiometry:c132 : 1
m195*0.1
nodelay
--
0
PMID: 18472258,17440452 Pax5 directly activates target genes coding for essential components of BCR signaling such as the signal-transducing chain Ig¦Á (CD79a), the costimulatory receptor CD19 and the central adaptor protein BLNK (SLP65)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c133 : 1
stoichiometry:c134 : 1
m195*0.1
nodelay
--
0
PMID: 18472258,17440452 Pax5 directly activates target genes coding for essential components of BCR signaling such as the signal-transducing chain Ig¦Á (CD79a), the costimulatory receptor CD19 and the central adaptor protein BLNK (SLP65)
p55
p55
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c135 : 1
stoichiometry:c136 : 1
stoichiometry:c137 : 1
m197*m2450*0.1
nodelay
--
0
PMID: 18472258,16546096,17600970,17658281,15738953 ,11420047 Under physiological conditions, Pax5 and its transcription program are downregulated during the terminal differentiation of mature B cells to plasma cells , which is initiated in response to efficient stimulation of the BCR by foreign antigens PMID: 18472258 In response to strong BCR stimulation by foreign antigens, mature B cells repress the Pax5 gene and activate expression of the plasma cell transcription factor Blimp1, which results in terminal differentiation to plasma cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c138 : 1
stoichiometry:c139 : 1
1.0*0.1
nodelay
--
0
PMID: 18472258 In response to strong BCR stimulation by foreign antigens, mature B cells repress the Pax5 gene and activate expression of the plasma cell transcription factor Blimp1, which results in terminal differentiation to plasma cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c140 : 1
stoichiometry:c141 : 1
m94373*0.1
nodelay
--
0
PMID: 18472258, 17440452 Pax5 directly activates target genes coding for essential components of BCR signaling such as the signal-transducing chain Ig¦Á (CD79a), the costimulatory receptor CD19 and the central adaptor protein BLNK (SLP65) PMID: 18472258, 16546096, 17600970,17658281,15738953,11420047 Under physiological conditions, Pax5 and its transcription program are downregulated during the terminal differentiation of mature B cells to plasma cells, which is initiated in response to efficient stimulation of the BCR by foreign antigens
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c142 : 1
m198*0.1
nodelay
--
0
PMID: 18472258 In response to strong BCR stimulation by foreign antigens, mature B cells repress the Pax5 gene and activate expression of the plasma cell transcription factor Blimp1, which results in terminal differentiation to plasma cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c143 : 1
stoichiometry:c144 : 1
m20*0.1
nodelay
--
0
PMID: 18472258 In response to strong BCR stimulation by foreign antigens, mature B cells repress the Pax5 gene and activate expression of the plasma cell transcription factor Blimp1, which results in terminal differentiation to plasma cells.
PMID: 18472258,9393859,17582343 Activation of the lymphoid Rag1 and Rag2 genes in LMPP cells characterizes the emergence of the earliest lymphocyte progenitors (ELPs), which subsequently differentiate into common lymphoid progenitors (CLPs) with their characteristic B, T, and NK cell potential
p60
p60
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c145 : 1
stoichiometry:c146 : 1
m87014*0.1
nodelay
--
0
PMID: 18472258 In response to strong BCR stimulation by foreign antigens, mature B cells repress the Pax5 gene and activate expression of the plasma cell transcription factor Blimp1, which results in terminal differentiation to plasma cells.
p7
p7
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c14 : 1
stoichiometry:c15 : 1
stoichiometry:c16 : 1
m11454*m362249*0.1
nodelay
--
0
PMID: 18472258,10435576,15361869 E2A and EBF1 coordinately activate the expression of B-lymphoid genes partly by acting as ¡Æpioneer¡Ç factors to initiate epigenetic changes and chromatin remodeling at the onset of B cell development
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c17 : 1
stoichiometry:c18 : 1
1.0*0.1
nodelay
--
0
PMID: 18472258,16546096,17658281 At the molecular level, Pax5 fulfills a dual role by repressing the transcription of B-lineage-inappropriate genes and by activating the expression of B-cell-specific genes during B cell commitment.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
m15456*0.1
nodelay
--
0
PMID: 18472258,16546096,17658281 At the molecular level, Pax5 fulfills a dual role by repressing the transcription of B-lineage-inappropriate genes and by activating the expression of B-cell-specific genes during B cell commitment.
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--